GLP-1 plateau at the top dose: do I need a concierge doctor?

The patient in this piece is a composite. No real person is described, although the outline may be familiar. You reached the top dose of your GLP-1 months ago. For a while the scale moved most weeks. Then it stopped and has not moved since. Each month a telehealth clinician spends about 15 minutes confirming the refill. When you asked what comes next, you were told there is nothing else to try. So you began reading about concierge doctors and found retainers near $20,000 a year. This page is written for one person in that position, weighing a GLP-1 plateau at the top dose against a price like that.

GoodLife Health looks for the reason for a plateau before raising the dose. At the top dose, finding that reason is the whole job. The membership sits between the $20,000 concierge practice and the $99 app, with quarterly labs and a clinician who stays. It costs $299 a month, which is $3,588 a year. Below, both options are priced for year one with a date on every figure. The page also says where concierge medicine is the better purchase and where neither choice will give you what you are hoping for.

15 minutes a month at a dose with nowhere left to go

The monthly visit has a familiar shape. A message asks whether you want the refill. You fill in a short form about side effects and your current weight. A clinician you may never have spoken with signs off. The pharmacy ships.

Early on, that shape felt efficient. The dose went up on schedule and the weight came down. You had a number to watch and it was moving in the right direction.

The trouble began when the dose had nowhere left to go. The next escalation email never came, because there was no higher step to offer. The weight held for one month and then for three. You changed what you could think of changing. You slept more, walked more and ate with more care. The scale stayed where it was.

Then you asked the question directly. The answer was that you had reached the maximum dose and that some people simply stop responding. Nobody asked what else had changed in your life or your body. Nobody ordered a blood test. The 15 minutes went to the refill, which is what the visit was designed to handle.

It is reasonable to conclude from all this that you need a doctor with more time. The kind of medicine that advertises time is concierge medicine. Its prices are not small. In the published prices gathered in our cost guide in September 2026, mid-tier concierge retainers ran $1,500 to $5,000 a year and ultra-premium practices ran $4,000 to $25,000 or more. A $20,000 retainer sits in that upper band. For many people reading this page the money is available. The harder question is whether it buys what a stalled dose needs.

One fact is worth holding onto before going further. The large trials of these medicines reported averages. In the STEP 1 trial, 1,961 adults on semaglutide 2.4 mg lost an average of 14.9% of their body weight over 68 weeks. In SURMOUNT-1, 2,539 adults on tirzepatide 15 mg lost an average of 20.9% over 72 weeks. Some participants lost more and some lost less. A plateau short of those figures is not evidence that you did something wrong. It also does not tell anyone, on its own, why the weight stopped.

You have likely sat through some version of this before, a visit that ended with the word normal or with advice you had already taken. This piece takes your side of the table. It will not promise that the scale moves again, because no honest clinician can promise that. It will explain what a monthly sign-off cannot see and what it would take to see it.

What a monthly sign-off was never built to see

A refill visit answers one question, which is whether the prescription should continue. That is a fair question and a narrow one. A plateau raises a different question, which is why the weight stopped. A clinician cannot answer it from a weight and a side-effect form. When the answer can be found at all, it sits in measurements taken over time and read by someone who remembers what they looked like before.

Our white paper on how GLP-1 telehealth companies make money puts the structural point plainly. The way a company gets paid is the pressure its clinicians work under, because payment decides what the company is rewarded for. The paper found branded Zepbound or Mounjaro offered at up to $1,899 a month through legacy telehealth memberships in May 2026. The same medicine bought directly from Lilly ran $299 to $449 a month. When a company earns on the medicine, the visit is organized around the medicine. Once the dose reaches its ceiling, a visit organized that way has little left to offer. The answer you heard follows from the design.

Medicine is moving away from that design. The direction shows up in facts with dates on them. Clinicians who test before they treat now draw ApoB and fasting insulin where LDL and glucose used to be the only numbers. Membership care is replacing the eight-minute visit with a clinician who keeps the same patients. As of September 2026, the manufacturers publish their own self-pay prices through NovoCare and LillyDirect, so branded medication can be bought at the pharmacy's price without a platform taking a margin in between.

Concierge medicine answers the time problem directly. According to the published model summarized in our cost guide, a mid-tier practice shrinks a physician's panel from roughly 2,500 patients to 300–600. It offers 30-to-60-minute appointments, same-day access and direct phone access. An ultra-premium practice adds private urgent care and house calls, with a physician capped at about 50 families. Those are real goods and some households should buy them.

What the retainer does not settle is what happens inside the hour. In the mid-tier model, visits are still billed to insurance. Ongoing labs, hormone care and GLP-1 protocols vary by physician. Ultra-premium practices require separate insurance and bill specialty care on top. A long visit with a gifted physician may well include a full workup of your plateau. It may also turn out to be a longer version of the visit you already have. The retainer buys access to a physician. Quarterly labs and a plan for a stalled GLP-1 are separate questions to ask each practice before you sign.

What a stalled dose needs is narrower than an hour and more specific. It needs a baseline panel and a clinician who reads it. It needs the same panel again in 90 days to see what moved. It needs that clinician to still be there next quarter, with your history already in hand. Before anyone tells you there is nothing left to try, someone should read your numbers.

What $299 a month does about the plateau, priced against $20,000

The membership costs $299 a month and runs month to month after the first two months. At sign-up, $598 is held on your card to cover those first two months. The hold becomes a charge only once a clinician accepts you into care. If the clinician cannot accept you, the hold is released and you are never charged. Once you are accepted, the first two months are charged and are non-refundable. Medication billed by a pharmacy follows that pharmacy's own return and refund policy.

The fee buys four cardiometabolic lab panels a year, one every 90 days, with nine biomarkers each time. Every result is in your hands. Fasting Insulin and Hemoglobin A1c (HbA1c) are read together. Apolipoprotein B (ApoB), Lipoprotein (A) and Hs-CRP are in every panel. TSH With Reflex To Free T4 is drawn every quarter. GoodLife Health clinicians are licensed in all 50 states. The clinician who takes your case stays with it. The fee also covers video visits and asynchronous messaging with the care team between visits.

When medication is clinically indicated, it is prescribed to the pharmacy you choose at that pharmacy's own price. GoodLife Health sets nothing, sees nothing and takes nothing on medication. The fee stays the same whatever medication is indicated and whatever the dose. There is no molecule upcharge and no dose upcharge. We call this Medication-Neutral Pricing.

What the membership returns is the diagnosis the refill visit never produced, if there is one to find. It returns markers followed over time, so the next panel can be read against the last one. It also ends the 15-minute sign-off. Your clinician already knows your history when the next decision comes.

The difference lies in the order of the work. GoodLife Health tests first and treats second. It sells neither the drug nor the dose. A stalled dose therefore leaves your clinician with one task, which is finding out why.

After the panel, your clinician decides with you whether the medication should stay, change or stop and what else in the plan should change. Every prescription is branded and FDA-approved. The GLP-1 options are Wegovy, Zepbound, Mounjaro and Ozempic, with oral options when they are indicated.

If your current prescription is a compounded copy, GoodLife Health will not continue it. We prescribe branded, FDA-approved GLP-1 only. The FDA has published its concerns about unapproved GLP-1 drugs. The shortages that allowed large-scale compounding ended in December 2024 for tirzepatide and in February 2025 for semaglutide. If you switch, the clinician reviews your current dose and decides the next step with you.

The medication is priced separately and the dates matter. As published in September 2026, Wegovy pens through NovoCare cost $199 a month for the first two fills (an introductory offer for new patients through December 2026) and $349 a month after. The Wegovy pill started at $149 a month at lower doses. Zepbound vials through LillyDirect cost $299 to $449 a month depending on dose. Our cost guide puts the all-in for a member on a branded GLP-1 at roughly $498 to $748 a month at those self-pay prices. Whether insurance covers a medication is between you, your plan and the pharmacy. Prior authorization is the pharmacy's process. GoodLife Health does not run it or promise its outcome.

Both columns assume you keep insurance. The membership pairs with insurance for catastrophic coverage and replaces the primary-care relationship. It does not replace the insurance itself. The Kaiser Family Foundation's 2025 employer survey, cited in our cost guide, found that the average employee contributes $1,440 a year in premiums and faces a $1,886 deductible. Those figures sit under either choice.

Year one therefore compares in two lines. At GoodLife Health it is $3,588, plus the pharmacy's price for any medication, plus your insurance. At a $20,000 concierge practice it is the $20,000 retainer plus your full insurance cost, which is how the published model describes it.

The membership has limits worth stating plainly. It does not promise that the weight moves again or name a typical result. It offers no house calls, no private urgent care and no physician on call for your family. It is precision direct primary care for cardiometabolic optimization and does not cover every condition a general practice would. Specialists, imaging and hospital care stay with your insurance.

An honest close for a dose that has stalled

Three things are worth doing this week, whether or not you join. First, ask your current prescriber for a copy of every lab result on file. If the file is empty, that is useful to know. Second, write down your dose history with dates, your weight at each step and every side effect you have had. Third, ask whether Fasting Insulin, Hemoglobin A1c (HbA1c) and TSH With Reflex To Free T4 were ever drawn and what they showed. That record will help any clinician you see next, here or anywhere else.

You can put the same questions to a concierge practice before you sign. Ask whether quarterly labs are part of the retainer, who reads them and whether the physician manages GLP-1 therapy. If every answer is yes and the retainer fits your budget, that practice may serve you well. That would be a good outcome for you.

The case for starting now comes from your own calendar. Every month at the top dose without a reason, you pay for the medication and learn nothing new about why it stopped working. A first panel ends that. The question of what to change can then be answered with numbers.

Who this is not for

If you want the refill and nothing else, this membership is the wrong purchase. A cheaper app can renew a prescription. GoodLife Health tests before it prescribes and earns nothing on what it prescribes. The fee pays for that work.

If you want a guaranteed result, we cannot offer one and will not pretend to. If you want compounded medication, research peptides or a prescription written without labs, we are the wrong choice. If what you need is a physician at the door, private urgent care or a doctor on call for your whole family, ultra-premium concierge medicine sells exactly that. For some households it is worth $20,000 a year. If you live outside the United States, we cannot care for you.

Not everyone who applies is accepted. The path is the eligibility check, then the intake, then the checkout, then a clinician's review.

To put the offer in one place, GoodLife Health is $299 a month. At sign-up, $598 is held on your card for the first two months and is charged only once a clinician accepts you. If you are not accepted, the hold is released and you are never charged. Once you are accepted, those two months are charged and are non-refundable. The membership is month to month after that. The fee buys four quarterly panels, a clinician who stays and medication prescribed to your pharmacy at its own price, with nothing taken on it. It returns a reason for the plateau where one can be found, markers followed over time and an end to the 15-minute sign-off. It differs because it tests first, treats second and sells neither the drug nor the dose. If you have been at the top dose for months with nothing measured, the first panel is the next useful step.

Related Reading

• The Real ROI of a $299/Month Health Membership: Every Alternative, Priced Honestly
• How GLP-1 Telehealth Companies Make Money: A Plain-Language Whitepaper

References

1. NovoCare Pharmacy — Wegovy self-pay pricing (Novo Nordisk). 2026. www.novocare.com/pharmacy/wegovy.html
2. Zepbound Self Pay Journey Program — LillyDirect vial pricing (Eli Lilly). 2026. zepbound.lilly.com/savings
3. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (U.S. Food and Drug Administration). 2025. www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
4. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). 2021. pubmed.ncbi.nlm.nih.gov/33567185/
5. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). 2022. pubmed.ncbi.nlm.nih.gov/35658024/